Sai Life Sciences Limited has informed the Exchange about Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2026.
SAILIFE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Sai Life Sciences Limited has submitted a regulatory compliance certificate under SEBI Regulation 74(5) for the quarter ending March 31, 2026. The certificate confirms that KFin Technologies Limited, the company's Registrar and Share Transfer Agent, has furnished details of securities dematerialized and rematerialized during the period to both NSDL and CDSL. This filing was submitted to BSE (Scrip Code: 544306) and NSE (Scrip Symbol: SAILIFE) on April 8, 2026. The certificate is dated April 2, 2026. This is a routine regulatory requirement under SEBI regulations governing depositories and participants.
This is a standard regulatory compliance filing with no direct impact on the company's financials or shareholder value. It confirms proper processing of share dematerialization/rematerialization requests during Q4 FY2026.